SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-003281
Filing Date
2022-03-10
Accepted
2022-03-10 16:10:51
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20211231x10k.htm   iXBRL 10-K 3006241
2 EX-10.18 crvs-20211231xex10d18.htm EX-10.18 259514
3 EX-21.1 crvs-20211231xex21d1.htm EX-21.1 6229
4 EX-23.1 crvs-20211231xex23d1.htm EX-23.1 1995
5 EX-31.1 crvs-20211231xex31d1.htm EX-31.1 14096
6 EX-31.2 crvs-20211231xex31d2.htm EX-31.2 14495
7 EX-32.1 crvs-20211231xex32d1.htm EX-32.1 7392
8 GRAPHIC crvs-20211231x10k007.jpg GRAPHIC 71376
  Complete submission text file 0001558370-22-003281.txt   11263849

Data Files

Seq Description Document Type Size
9 EX-101.SCH crvs-20211231.xsd EX-101.SCH 60716
10 EX-101.CAL crvs-20211231_cal.xml EX-101.CAL 66663
11 EX-101.DEF crvs-20211231_def.xml EX-101.DEF 193634
12 EX-101.LAB crvs-20211231_lab.xml EX-101.LAB 569804
13 EX-101.PRE crvs-20211231_pre.xml EX-101.PRE 400699
82 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20211231x10k_htm.xml XML 2122758
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 22729169
SIC: 2834 Pharmaceutical Preparations